Ute Oltmanns

1.8k total citations
28 papers, 1.2k citations indexed

About

Ute Oltmanns is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Ute Oltmanns has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 5 papers in Oncology. Recurrent topics in Ute Oltmanns's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Asthma and respiratory diseases (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Ute Oltmanns is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Asthma and respiratory diseases (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Ute Oltmanns collaborates with scholars based in Germany, United Kingdom and United States. Ute Oltmanns's co-authors include Kian Fan Chung, Maria B. Sukkar, Razao Issa, Matthias John, Karin Palmowski, Michael Kreuter, Shaoping Xie, Felix Herth, Claus Peter Heußel and Svenja Ehlers-Tenenbaum and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and European Respiratory Journal.

In The Last Decade

Ute Oltmanns

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Oltmanns Germany 18 717 429 189 166 125 28 1.2k
Christina K. Haston Canada 24 852 1.2× 146 0.3× 354 1.9× 153 0.9× 126 1.0× 58 1.4k
Sohei Makino Japan 18 440 0.6× 723 1.7× 164 0.9× 246 1.5× 103 0.8× 99 1.3k
Mikio Kataoka Japan 23 494 0.7× 434 1.0× 239 1.3× 204 1.2× 103 0.8× 66 1.2k
Sonoko Nagai Japan 12 407 0.6× 304 0.7× 156 0.8× 80 0.5× 24 0.2× 28 727
Fayong Luo United States 14 552 0.8× 114 0.3× 337 1.8× 156 0.9× 112 0.9× 15 1.1k
A B Tonnel France 21 778 1.1× 1.0k 2.3× 169 0.9× 476 2.9× 80 0.6× 56 1.9k
Aaron M. Gibson United States 20 192 0.3× 441 1.0× 317 1.7× 371 2.2× 78 0.6× 32 1.3k
Sven Michel Germany 19 239 0.3× 480 1.1× 438 2.3× 367 2.2× 97 0.8× 40 1.3k
Suzanne Traves Canada 23 679 0.9× 613 1.4× 317 1.7× 471 2.8× 149 1.2× 32 1.5k
Annemie J. Schuerwegh Belgium 23 167 0.2× 266 0.6× 227 1.2× 409 2.5× 137 1.1× 44 1.6k

Countries citing papers authored by Ute Oltmanns

Since Specialization
Citations

This map shows the geographic impact of Ute Oltmanns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Oltmanns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Oltmanns more than expected).

Fields of papers citing papers by Ute Oltmanns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Oltmanns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Oltmanns. The network helps show where Ute Oltmanns may publish in the future.

Co-authorship network of co-authors of Ute Oltmanns

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Oltmanns. A scholar is included among the top collaborators of Ute Oltmanns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Oltmanns. Ute Oltmanns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonella, Francesco, et al.. (2020). Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysis. BMC Pulmonary Medicine. 20(1). 128–128. 8 indexed citations
2.
Manen, Mirjam J.G. van, Michael Kreuter, Bernt van den Blink, et al.. (2017). What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany. ERJ Open Research. 3(1). 65–2016. 27 indexed citations
3.
Kreuter, Michael, Svenja Ehlers-Tenenbaum, Karin Palmowski, et al.. (2016). Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis. PLoS ONE. 11(3). e0151425–e0151425. 209 indexed citations
4.
Oltmanns, Ute, Karin Palmowski, Mark O. Wielpütz, et al.. (2015). Optical coherence tomography detects structural abnormalitiesof the nasal mucosa in patients with cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 216–222. 17 indexed citations
5.
Oltmanns, Ute, Nicolas Kahn, Karin Palmowski, et al.. (2014). Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-Life Experience from a German Tertiary Referral Center for Interstitial Lung Diseases. Respiration. 88(3). 199–207. 77 indexed citations
6.
7.
Oltmanns, Ute, Nicolas Kahn, Heinrich Wenz, et al.. (2013). Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases. European Respiratory Journal. 42(Suppl 57). P2335–P2335. 4 indexed citations
8.
Navani, Neal, Matthew Nankivell, Ian Woolhouse, et al.. (2011). Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy: A Multicenter Study. Journal of Thoracic Oncology. 6(9). 1505–1509. 64 indexed citations
9.
Oltmanns, Ute, Maria B. Sukkar, Sherry Xie, et al.. (2007). Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle. Pulmonary Pharmacology & Therapeutics. 21(2). 292–297. 16 indexed citations
10.
John, Matthias, et al.. (2005). Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. Respiratory Medicine. 99(11). 1418–1424. 28 indexed citations
11.
Oltmanns, Ute, Kian Fan Chung, Matthew J. Walters, Matthias John, & Jane A. Mitchell. (2005). Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respiratory Research. 6(1). 74–74. 89 indexed citations
12.
Oltmanns, Ute, et al.. (2005). Induction of Human Airway Smooth Muscle Apoptosis by Neutrophils and Neutrophil Elastase. American Journal of Respiratory Cell and Molecular Biology. 32(4). 334–341. 33 indexed citations
13.
14.
Xie, Shaoping, Maria B. Sukkar, Razao Issa, et al.. (2004). Regulation of TGF-β1-induced connective tissue growth factor expression in airway smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(1). L68–L76. 83 indexed citations
15.
Oltmanns, Ute, Razao Issa, Maria B. Sukkar, Matthias John, & Kian Fan Chung. (2003). Role of c‐jun N‐terminal kinase in the induced release of GM‐CSF, RANTES and IL‐8 from human airway smooth muscle cells. British Journal of Pharmacology. 139(6). 1228–1234. 82 indexed citations
16.
Oltmanns, Ute, et al.. (2003). INCREASED SPONTANEOUS INTERLEUKIN-10 RELEASE FROM ALVEOLAR MACROPHAGES IN ACTIVE PULMONARY SARCOIDOSIS. Experimental Lung Research. 29(5). 315–328. 24 indexed citations
17.
John, Matthias, Ute Oltmanns, Claudia R. Binder, et al.. (2003). Inhibition of chemokine production from human airway smooth muscle cells by fluticasone, budesonide and beclomethasone. Pulmonary Pharmacology & Therapeutics. 17(1). 41–47. 16 indexed citations
18.
Rancan, Fiorenza, Ernesto Fernández, María Eliana Hidalgo, et al.. (2002). Protection against UVB irradiation by natural filters extracted from lichens. Journal of Photochemistry and Photobiology B Biology. 68(2-3). 133–139. 88 indexed citations
19.
John, Matthias, Ute Oltmanns, Ingo Fietze, Christian Witt, & Klaus Jung. (2002). INCREASED PRODUCTION OF MATRIX METALLOPROTEINASE-2 IN ALVEOLAR MACROPHAGES AND REGULATION BY INTERLEUKIN-10 IN PATIENTS WITH ACUTE PULMONARY SARCOIDOSIS. Experimental Lung Research. 28(1). 55–68. 21 indexed citations
20.
John, Matthias, Ingo Fietze, Adrian C. Borges, et al.. (2001). Quantification of the Effect of Inhaled Budesonide on Airway Inflammation in Intermittent Asthma by Bronchitis Index. Journal of Asthma. 38(7). 593–599. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina K. Haston Breakdown of academic impact, for papers by Sohei Makino Breakdown of academic impact, for papers by Mikio Kataoka Breakdown of academic impact, for papers by Sonoko Nagai Breakdown of academic impact, for papers by Fayong Luo Breakdown of academic impact, for papers by A B Tonnel Breakdown of academic impact, for papers by Aaron M. Gibson Breakdown of academic impact, for papers by Sven Michel Breakdown of academic impact, for papers by Suzanne Traves Breakdown of academic impact, for papers by Annemie J. Schuerwegh
Rankless by CCL
2026